RELAPSED OSTEOSARCOMA
Clinical trials for RELAPSED OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RELAPSED OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids and adults with returning bone cancer?
Disease control Recruiting nowThis early-phase trial tests a new drug called tegavivint combined with the chemotherapy gemcitabine in people whose osteosarcoma (a type of bone cancer) has returned or not responded to treatment. The main goal is to find the safest dose of the combination and see if it can cont…
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
Immune cell combo offers new hope for kids with resistant cancers
Disease control Recruiting nowThis study is for children with neuroblastoma or osteosarcoma that has come back or not responded to treatment. It tests a new approach: giving donor immune cells (gamma delta T cells) along with standard chemotherapy and an antibody drug. The main goal is to find the safest dose…
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 06, 2026 16:01 UTC